We investigated facial palsy which was induced by the interruption of the petrosal artery in guinea pigs. Forty animals were observed for 2 months regarding their behavioral facial nerve function and assessed by the blink reflex. Morphological changes in the intratemporal portion were observed with transmission electron microscopy in 20 animals with an interrupted petrosal artery. Facial palsy developed in 85.0% within 3 days after the interruption. The degree of palsy varied from mild to severe. Remission of palsy required 2–3 months in severe cases, 3 weeks or less in mild/moderate cases. Histological studies revealed a striking difference in the degree of degenerative changes between severe cases and mild/moderate cases. Animals with severe palsy showed extensive axonal atrophy and myelin disruption from the early stage. Meanwhile, degenerative changes were slight in cases with mild/moderate palsy. Regenerating unmyelinated fibers appeared 1 week after the interruption, but diminished in number 4 weeks later. Thereafter, new myelin was reformed on fibers. In cases of severe nerve damage, however, this regeneration process did not always seem to work well. A decrease in number and an irregular shape of the fibers were noted in animals with incomplete recovery. This animal model may be helpful for understanding the pathophysiology of ischemic facial palsy.

Keywords:
Facial nerve, Facial palsy, Nerve degeneration, Nerve regeneration, Petrosal artery
This content is only available via PDF.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.